Evaluation of the Prevalence and Laboratory Test Results of Overt Thyrotoxicosis Cases

1 TÜRKIYE ENDOKRINOLOJI VE METABOLIZMA DERNEĞI. Hipertiroidi ve Tirotoksikoz. Tiroid Hastalıkları Tanı ve Tedavi Klavuzu. 2023: 95-109. Search in Google Scholar

2 SHARMA A, STAN MN. Thyrotoxicosis: Diagnosis and Management. Mayo Clin Proc. 2019; 94(6): 1048-1064. Search in Google Scholar

3 VAN SOESTBERGEN M, VAN DER VIJVER J, GRAAFLAND A. Recurrence of hyperthyroidism in multinodular goiter after long-term drug therapy: a comparison with Graves’ disease. Journal of endocrinological investigation. 2012; 15(11): 797-800. Search in Google Scholar

4 DE LEO S, LEE SY, BRAVERMAN LE. Hyperthyroidism. Lancet (London, England). 2016; 388(10047): 906-18. Search in Google Scholar

5 ALFADDA AA, SALLAM RM, ELAWAD GE, ALDHUKAIR H, ALYAHYA MM. Subacute thyroiditis: clinical presentation and long term outcome. Int J Endocrinol. 2014;2014:794943. Search in Google Scholar

6 ROSS DS, BURCH HB, COOPER DS, GREENLEE MC, LAURBERG P, MAIA AL, et al. American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016; 26(10):1343-1421 Search in Google Scholar

7 AZEEZ TA, LAMIDI AO, OSIN IO. A systematic review and meta-analysis of the etiology and treatment patterns of thyrotoxicosis in Africa. Expert Rev Endocrinol Metab. 2022; 17(6):563-572 Search in Google Scholar

8 DAĞLI Ş. AİBÜ. İzzet Baysal Tıp Fakültesi Hastanesi, İç Hastalıkları polikliniğine 2007 yılında başvuran hastalardaki tiroid patolojilerinin dağılımı. Search in Google Scholar

9 KINOSHITA S, HAYASHI T, WADA K, YAMATO M, KUWAHARA T, ANZAI T, et al. Risk factors for amiodarone-induced thyroid dysfunction in Japan. J Arrhythm. 2016; 32: 474-480. Search in Google Scholar

10 BEDNARCZUK T, BRIX TH, SCHIMA W, ZETTINIG G, KAHALY GJ. European Thyroid Association Guidelines for the Management of Iodine-Based Contrast Media-Induced Thyroid Dysfunction. Eur Thyroid J. 2021;10(4):269-284. Search in Google Scholar

11 MAMMEN JS, MCGREADY J, OXMAN R, CHİA CW, LADENSON PW, SİMONSİCK EM. Thyroid Hormone Therapy and Risk of Thyrotoxicosis in Community-Resident Older Adults: Findings from the Baltimore Longitudinal Study of Aging. Thyroid : Official Journal of the American Thyroid Association. 2015; 25(9):979-986. Search in Google Scholar

12 DE BENOIST B, ANDERSSON M, TAKKOUCHE B, EGLI I. Prevalence of iodine deficiency worldwide. Lancet (London, England). 2003; 362(9398): 1859-60. Search in Google Scholar

13 ROSS DS. Treatment of toxic adenoma and toxic multinodular goiter. UpToDate 12th ed. Waltham, MA: Wolters Kluwer. 2019. Search in Google Scholar

14 NOVODVORSKY P, ALLAHABADIA A. Thyrotoxicosis. Medicine. 2017; 45(8): 510-516. Search in Google Scholar

15 AKBAR DH, MUSHTAQ MM, AL-SHEIK AA. Etiology and outcome of thyrotoxicosis at a university hospital. Saudi medical journal. 2000; 21(4): 352-4. Search in Google Scholar

16 BLICK C, NGUYEN M, JIALAL I. Thyrotoxicosis In: StatPearls [Internet]. Treasure Island (FL) StatPearls Publishing. 2022. Search in Google Scholar

17 ERGÜN Y, TUZCU AK. Subakut tiroidit tanılı hastaların demografik özellikleri ve laboratuvar verilerinin analizi: tek merkez deneyimi. Ege Tıp Dergisi. 2019; 58(3): 282-288. Search in Google Scholar

18 TURA BAHADIR Ç, YILMAZ M, KILIÇKAN E. Free triiodothyronine to free thyroxine ratio in the differential diagnosis of thyrotoxicosis and hyperthyroidism: A retrospective study. Int J Clin Pract. 2021; 75:e14003 Search in Google Scholar